Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Cancer Med ; 12(10): 11284-11292, 2023 05.
Article in English | MEDLINE | ID: mdl-36965095

ABSTRACT

BACKGROUND: Previous studies had explored the diagnostic or prognostic value of NRP-1/CD304 in blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML), and B-cell acute lymphoblastic leukemia (B-ALL), whereas the expression and application value of NRP-1/CD304 in other common hematological diseases have not been reported. METHODS: Bone marrow samples from 297 newly diagnosed patients with various hematological diseases were collected to detect the expression of NRP-1/CD304 by flow cytometry (FCM). The diagnostic efficacy of NRP-1/ CD304-positive diseases was analyzed by receiver operating characteristic (ROC) curve, and the area under the ROC curve (AUC) was compared. RESULTS: In the research cohort, the total positive rate of NRP-1/CD304 was 14.81% (44/297), mainly distributed in BPDCN (100%, 6/6), B-ALL (48.61%, 35/72), and AML (4.48%, 3/67), with statistically significant differences (p < 0.01). Other diseases, such as T-cell acute lymphoblastic leukemia (T-ALL), B-cell non-Hodgkin lymphoma (B-NHL), T/NK-cell lymphoma and plasma cell neoplasms, did not express NRP-1/CD304. The AUC of NRP-1/CD304 was 0.936 (95% CI 0.898-0.973), 0.723 (95% CI 0.646-0.801), and 0.435 (95% CI 0.435) in BPDCN, B-ALL and AML, respectively. Besides, CD304 was commonly expressed in B-ALL with BCR-ABL1 gene rearrangement (p = 0.000), and CD304 expression was positively correlated with CD34 co-expression (p = 0.009) and CD10 co-expression (p = 0.007). CONCLUSIONS: NRP-1/CD304 is only expressed in BPDCN, B-ALL and AML, but not in other common hematological diseases. This indicates that NRP-1/CD304 has no obvious diagnostic and follow-up study value in hematological diseases other than BPDCN, B-ALL, and AML.


Subject(s)
Hematologic Diseases , Leukemia, Myeloid, Acute , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma , Humans , Follow-Up Studies , Leukemia, Myeloid, Acute/diagnosis , Prognosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/metabolism , Acute Disease
2.
Zhongguo Zhong Yao Za Zhi ; 41(4): 728-730, 2016 Feb.
Article in Chinese | MEDLINE | ID: mdl-28871701

ABSTRACT

To investigate the effects of Yupingfeng granule (YPF) on immune factors of the rats with allergic rhinitis (AR) induced by ovalbumin(OVA). OVA 0.3 mg, Al(OH)3 30 mg and saline 1 mL were mixed and intraperitoneally injected for the initial immunization, 4% OVA 200 µg (50 µL) was given to the nose on the 15th day for the second immunization to establish the allergic rhinitis model. Sixty male SD rats were randomly divided into allergic rhinitis(AR) model group, Yupingfeng granule three dose (2.7,1.35,0.68 g•kg⁻¹) groups, control drug Biyankang (0.4 g•kg⁻¹) and normal control group. After 14 days, efforts were made to collect blood from abdominal aorta, and take nasopharynx tissues and fasten them into 10% formaldehyde for a pathological examination. The levels of HIS, IgE, IL-4 and TNF-α in serum were examined by radioimmunoassay, and nasal mucosa tissues were examined by HE staining. According to the results, the levels of HIS, IgE, IL-4 and TNF-α in serum of Yupingfeng granule groups were significantly lower than that of AR model group (P<0.05, P<0.01). Nasal mucosa tissues showed slight morphological changes and inflammatory cell infiltration, with unobvious necrosis. Yupingfeng granule can improve the pathological changes of nasal mucosa tissues, and reduce the production and release of immune factors during allergic rhinitis (AR) process in vivo by OVA, which may be the important curative mechanism of allergic rhinitis.


Subject(s)
Cytokines/immunology , Drugs, Chinese Herbal/administration & dosage , Rhinitis, Allergic/drug therapy , Animals , Cytokines/genetics , Disease Models, Animal , Humans , Male , Nasal Mucosa/drug effects , Nasal Mucosa/immunology , Ovalbumin/adverse effects , Rats , Rats, Sprague-Dawley , Rhinitis, Allergic/chemically induced , Rhinitis, Allergic/genetics , Rhinitis, Allergic/immunology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
3.
Huan Jing Ke Xue ; 28(5): 1165-8, 2007 May.
Article in Chinese | MEDLINE | ID: mdl-17633197

ABSTRACT

Plastic material is one of the most serious solid wastes pollution. More than 40 million tons of plastics produced each year are discarded into environment. Plastics accumulated in the environment is highly resistant to biodegradation and not be able to take part in substance recycle. To increase the biodegradation efficiency of plastics by different means is the main research direction. This article reviewed the recent research works of polyethylene biodegradation that included the modification and pretreatment of polyethylene, biodegradation pathway, the relevant microbes and enzymes and the changes of physical, chemical and biological properties after biodegradation. The study directions of exploiting the kinds of life-forms of biodegradation polyethylene except the microorganisms, isolating and cloning the key enzymes and gene that could produce active groups, and enhancing the study on polyethylene biodegradation without additive were proposed.


Subject(s)
Bacteria/metabolism , Industrial Waste/prevention & control , Polyethylene/metabolism , Refuse Disposal/methods , Biodegradation, Environmental , Industrial Waste/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...